S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   393.90 (-1.45%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   393.90 (-1.45%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   393.90 (-1.45%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,592.41 (-1.35%)
DOW   34,632.41 (-1.43%)
QQQ   393.90 (-1.45%)
AAPL   163.94 (+2.31%)
MSFT   331.12 (-1.64%)
FB   327.49 (-3.12%)
GOOGL   2,850.95 (-2.05%)
AMZN   3,508.17 (-1.50%)
TSLA   1,132.11 (-0.43%)
NVDA   322.53 (-3.36%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.46 (-5.42%)
AMD   157.27 (-2.87%)
GE   94.86 (-3.60%)
MU   84.83 (-1.52%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
NASDAQ:PLRX

Pliant Therapeutics SEC Filings & 10K Form

$13.74
-0.33 (-2.35%)
(As of 11/30/2021 01:45 PM ET)
Add
Compare
Today's Range
$13.23
$14.03
50-Day Range
$14.07
$18.26
52-Week Range
$13.81
$43.92
Volume
2,851 shs
Average Volume
132,346 shs
Market Capitalization
$495.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1

Pliant Therapeutics (NASDAQ:PLRX) SEC Filings

DateFilerForm TypeView
09/07/2021
6:31 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2021
4:07 PM
Pliant Therapeutics (Filer)
Form S-3ASR
07/01/2021
7:14 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4/A
06/30/2021
7:49 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
7:47 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
7:37 PM
HOMCY CHARLES J (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
7:30 PM
Exter Neil (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
7:24 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
6:50 PM
Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:52 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
7:03 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:58 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
6:34 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
4:16 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2021
3:49 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
2:40 PM
Pliant Therapeutics (Filer)
Form DEFA14A
04/30/2021
2:37 PM
Pliant Therapeutics (Filer)
Form DEF 14A
04/15/2021
7:05 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
6:09 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2021
6:36 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
4:14 PM
Pliant Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/16/2021
3:15 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2021
7:51 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
2:41 PM
CHI Advisors LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/17/2021
6:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Howes Barbara (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2021
7:00 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
6:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
5:15 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
5:00 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2021
4:08 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
7:00 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
7:00 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
7:00 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
5:05 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
7:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
7:00 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
3:22 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/10/2020
3:18 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
7:00 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
7:00 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/11/2020
3:24 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2020
3:15 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
10:38 AM
FMR LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
06/15/2020
3:40 PM
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
06/09/2020
8:24 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:21 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:08 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:03 PM
Howes Barbara (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:01 PM
LEVIN MARK J (Reporting)
Pliant Therapeutics (Issuer)
STARR KEVIN P (Reporting)
TEPPER ROBERT I (Reporting)
Third Rock Ventures GP III, L.P. (Reporting)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures III, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP III, LLC (Reporting)
TRV GP IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:00 PM
Exter Neil (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
8:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:27 PM
Pliant Therapeutics (Filer)
Form 424B4
06/02/2020
11:15 PM
Pliant Therapeutics (Filer)
Form EFFECT
06/02/2020
8:17 PM
Green Jeremy (Reporting)
Pliant Therapeutics (Issuer)
Redmile Group, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:12 PM
Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:10 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:07 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:05 PM
LEVIN MARK J (Reporting)
Pliant Therapeutics (Issuer)
STARR KEVIN P (Reporting)
TEPPER ROBERT I (Reporting)
Third Rock Ventures GP III, L.P. (Reporting)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures III, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP III, LLC (Reporting)
TRV GP IV, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:03 PM
CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:03 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:02 PM
Howes Barbara (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:02 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:01 PM
Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:01 PM
Exter Neil (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:00 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:00 PM
HOMCY CHARLES J (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
8:00 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
5:08 AM
Pliant Therapeutics (Filer)
Form S-1/A
06/01/2020
8:19 AM
Pliant Therapeutics (Filer)
Form CERT
05/26/2020
5:14 AM
Pliant Therapeutics (Filer)
Form S-1/A
05/08/2020
8:49 PM
Pliant Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/11/2020
10:53 AM
Pliant Therapeutics (Filer)
Form D/A
07/20/2018
2:31 PM
Pliant Therapeutics (Filer)
Form D/A
07/20/2018
1:25 PM
Pliant Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.